MicroRNA-455-3p promotes TGF-β signaling and inhibits osteoarthritis development by directly targeting PAK2

Shu Hu1, Xiaoyi Zhao1, Guping Mao1

  • 1Department of Joint Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.

Insights

MicroRNAs (miRNAs) regulate osteoarthritis (OA) by targeting P21-activated kinase 2 (PAK2). Suppressing PAK2 inhibits cartilage degeneration, suggesting miR-455-3p and PAK2 as potential OA therapeutics.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Biology

Background:

  • MicroRNAs (miRNAs) are implicated in osteoarthritis (OA) pathogenesis.
  • P21-activated kinases (PAKs) role in OA remains understudied.
  • Investigating miR-455-3p's regulation of cartilage degeneration via PAK2.

Purpose of the Study:

  • Determine if miR-455-3p targets PAK2 to influence OA.
  • Elucidate the molecular mechanisms of miR-455-3p in chondrogenesis and OA.
  • Evaluate therapeutic potential of miR-455-3p and PAK2 in OA.

Main Methods:

  • Utilized miR-455-3p knockout mice to assess cartilage integrity.
  • Analyzed miR-455-3p and PAK2 expression in human adipose-derived stem cell (hADSC) chondrogenesis and OA chondrocytes.
  • Performed luciferase reporter assays to confirm direct targeting of PAK2 mRNA 3'-UTRs by miR-455-3p.
  • Investigated effects of PAK inhibition (IPA-3) and PAK2 suppression on chondrocyte gene expression and TGF-β/Smad signaling.

Main Results:

  • miR-455-3p knockout mice exhibited significant knee cartilage degeneration.
  • miR-455-3p expression was upregulated, while PAK2 expression was downregulated in late-stage hADSC chondrogenesis and OA chondrocytes.
  • Overexpression of miR-455-3p or suppression of PAK2 upregulated cartilage-specific genes and downregulated hypertrophy-related genes.
  • miR-455-3p directly targets PAK2 mRNA.
  • PAK inhibition and PAK2 suppression promoted R-Smad activation in the TGF-β/Smad pathway.
  • IPA-3 treatment ameliorated OA-induced cartilage degeneration.

Conclusions:

  • miR-455-3p inhibits cartilage degeneration in OA by directly suppressing PAK2.
  • This regulation involves the promotion of TGF-β/Smad signaling in chondrocytes.
  • miR-455-3p represents a potential therapeutic agent, while PAK2 is a potential therapeutic target for OA treatment.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K